Inventor · disambiguated record
Adrian St. Clair Brown
Also filed as: BROWN ADRIAN · BROWN ADRIAN ST CLAIR
17 granted patents·17 pending applications·276 citations·filing 1994–2025
94Inventor score
Top patents by PatentIndex Score
34 records- 0197US11098015B2Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2021·Granted Aug 24, 2021·9 cites·3 claims
- 0297US11091440B2Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2021·Granted Aug 17, 2021·8 cites·3 claims
- 0397US11091439B2Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancerEXELIXIS INC·Filed 2020·Granted Aug 17, 2021·8 cites·5 claims
- 0495US9809549B2Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancerEXELIXIS INC·Filed 2014·Granted Nov 7, 2017·30 cites·5 claims
- 0594US8877776B2(L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideBROWN ADRIAN ST CLAIR·Filed 2010·Granted Nov 4, 2014·61 cites·5 claims
- 0692US12275706B2Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2024·Granted Apr 15, 2025·0 cites·6 claims
- 0791US6077532APharmaceutical ion exchange resin compositionEURO CELTIQUE SA·Filed 1996·Granted Jun 20, 2000·109 cites·14 claims
- 0889US2024279181A1Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0985US2023167063A1Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2023·Application pending·0 cites
- 1084US10590102B2Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanoneEXELIXIS INC·Filed 2017·Granted Mar 17, 2020·2 cites·9 claims
- 1181US2025243165A1Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2025·Application pending·0 cites
- 1279US2022033357A1Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 1378US2022259151A9Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 1477US8361498B2Pharmaceutical formulationCAPSUGEL BELGIUM NV·Filed 2010·Granted Jan 29, 2013·3 cites·23 claims
- 1574US8147871B2Pharmaceutical formulationsBROWN ADRIAN·Filed 2005·Granted Apr 3, 2012·3 cites·32 claims
- 1673US2020190032A1Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancerEXELIXIS INC·Filed 2020·Application pending·0 cites
- 1772US7842308B2Pharmaceutical formulationSMITHKLINE BEECHAM LTD·Filed 2002·Granted Nov 30, 2010·6 cites·22 claims
- 1869US7883721B2Pharmaceutical formulationSMITHKLINE BEECHAM LTD·Filed 2002·Granted Feb 8, 2011·4 cites·15 claims
- 1967US11254649B2Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanoneEXELIXIS INC·Filed 2020·Granted Feb 22, 2022·0 cites·15 claims
- 2067US2011117190A1Pharmaceutical FormulationsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2167US2018002289A1Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2017·Application pending·0 cites
- 2267US2018037552A1Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2017·Application pending·0 cites
- 2367US2017275251A1Malate salt of N-(4-phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancerEXELIXIS INC·Filed 2017·Application pending·0 cites
- 2466US2022056010A1Crystalline fumarate salt of (s)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanoneEXELIXIS INC·Filed 2021·Application pending·0 cites
- 2564US8673350B2Pharmaceutical formulationsMCALLISTER STEPHEN MARK·Filed 2004·Granted Mar 18, 2014·1 cites·26 claims
- 2661US2009148518A1Pharmaceutical FormulationsBROWN ADRIAN·Filed 2008·Application pending·0 cites
- 2756US5508044ADiltiazem pharmaceutical spheroid formulationEURO CELTIQUE SA·Filed 1994·Granted Apr 16, 1996·20 cites·2 claims
- 2854US2005175687A1Pharmaceutical formulationsFiled 2004·Application pending·0 cites
- 2953US8367101B2Pharmaceutical formulationCAPSUGEL BELGIUM NV·Filed 2002·Granted Feb 5, 2013·0 cites·4 claims
- 3052US2010074947A1Pharmaceutical FormulationsBROWN ADRIAN·Filed 2009·Application pending·0 cites
- 3148US5525355ALaxative compositionsEURO CELTIQUE SA·Filed 1994·Granted Jun 11, 1996·12 cites·14 claims
- 3247US2011300212A1Pharmaceutical FormulationMCALLISTER STEPHEN MARK·Filed 2011·Application pending·0 cites
- 3345US2012196940A1Pharmaceutical formulationsBROWN ADRIAN·Filed 2012·Application pending·0 cites
- 3440US2006057201A1Multicomponent pharmaceutical dosage formBONNEY STANLEY G·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian St. Clair Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →